Leslie D. Bell
16Patents
9h-index
20Co-inventors
68Inventor score
Filing activity: Jun 22, 1984 → Aug 25, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4935233A | Covalently linked polypeptide cell modulators | Emerging Cross-Sectional Technologies | 245 | Expired |
| US5114711A | Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates | Emerging Cross-Sectional Technologies | 64 | Expired |
| US4914033A | Structure and properties of modified interferons | Emerging Cross-Sectional Technologies | 30 | Expired |
| US4751077A | Interferons with novel cysteine pattern | Emerging Cross-Sectional Technologies | 23 | Expired |
| US4769233A | Structure and properties of modified interferons | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4738844A | Modified (1-28) beta interferons | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6130333A | Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use | Chemistry; Metallurgy | 10 | Expired |
| US4753795A | Modified (80-113) beta interferons | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4793995A | Modified (1-56) beta interferons | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4738845A | Modified (115-145) beta interferons | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4719180A | Synthetic urogastrone gene, corresponding plasmid recombinants, transformed cells, production thereof and urgastrone expression | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4963357A | Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor | Human Necessities | 4 | Expired |
| US6545124B1 | Peptide linkers for covalent linking polypeptide cell modulators | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5037752A | Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277 | Human Necessities | 2 | Expired |
| US5100666A | Modified tissue plasminogen activator K2K2SP | Human Necessities | 2 | Expired |
| US5244676A | Modified tissue plasminogen activator with modified glycosylation site | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.